PartiQlar Pure NMN Review (2026): EffePharm Uthever NMN with Published COA

Who Is PartiQlar?

PartiQlar is a supplement brand focused exclusively on longevity compounds. Unlike brands that sell dozens of products across categories, PartiQlar's entire product line consists of single-ingredient longevity supplements, primarily NMN. This narrow focus is the brand's identity: one molecule per product, at maximum purity, with nothing added.

The company manufactures in FDA-registered, cGMP-certified facilities in the United States. Its NMN is sourced from EffePharm, a Chinese pharmaceutical company that produces the Uthever branded NMN ingredient. This is a significant detail: Uthever NMN is the specific raw material used in several published human clinical trials, including studies that contributed to the broader NMN evidence base. When PartiQlar says its NMN is "clinically tested," it is referencing the raw material's research history, not a clinical trial of the PartiQlar product itself. This is a common but important distinction in supplement marketing.

PartiQlar sells exclusively through its own website. It is not available on Amazon, Walmart, or other third-party retailers. The company states this is to maintain product integrity and prevent counterfeiting, a legitimate concern in the NMN market where relabeled products with unknown origins are widespread.

The Formula: What Is (and Is Not) in the Capsule

PartiQlar's supplement facts panel is one of the shortest in the NMN category:

Component	Amount
β-Nicotinamide Mononucleotide (NMN)	500 mg
Other ingredients	Vegetable cellulose capsule

That is the entire formula. No TMG, no resveratrol, no B vitamins, no proprietary blends, no microcrystalline cellulose, no silica, no magnesium stearate. Compare this to Cymbiotika (five active ingredients, four at sub-clinical doses), Micro Ingredients (ten ingredients with undisclosed individual doses), or Dr. Love (NMN + TMG + B vitamins). PartiQlar has made a deliberate choice to exclude everything except the core molecule.

This approach has a clear advantage: you know exactly what you are taking and at what dose. There is no guesswork about whether the resveratrol is at a clinical threshold (it is not included) or whether the TMG dose is meaningful (it is not included). The disadvantage is equally clear: if you want companion ingredients, you need to buy and take them separately.

500 mg at 99% Purity: How It Stacks Up

PartiQlar's 500 mg dose matches the standard used in the majority of published NMN human trials. The Yoshino trial in Science used 250 mg (Yoshino et al., 2021, PMID: 33888596), the Yi dose-ranging trial tested 300/600/900 mg and found the strongest NAD+ response at 600 and 900 mg (Yi et al., 2023, PMID: 36482258), and the Igarashi trial showed benefit at 250 mg in older men (Igarashi et al., 2022, PMID: 35927255). At 500 mg, PartiQlar sits in the middle of the clinically validated range, above the minimum effective dose and below the point of diminishing returns.

The 99% purity claim is standard for established NMN brands using pharmaceutical-grade raw material. EffePharm's Uthever NMN is produced under ISO 9001 quality management and comes with its own COA at the raw material level. PartiQlar then tests the finished product at the batch level and publishes those results. This two-layer verification (raw material + finished product) is the most transparent approach available in the NMN supplement market.

The EffePharm Connection: Why the NMN Source Matters

PartiQlar publicly identifies EffePharm as its NMN supplier. This is more transparency than most NMN brands provide, and it matters for a specific reason: EffePharm's Uthever NMN is the raw material that has been tested in published human clinical trials. When a brand uses Uthever and discloses it, the consumer can trace the supply chain from the published research to the raw material to the finished product. This traceability is unusual in the supplement industry.

For comparison, ProHealth Longevity also uses and discloses Uthever NMN. Wonderfeel uses a named NMN source. Force Factor, Nutricost, and generic Amazon NMN Beta products do not disclose their NMN source. Cymbiotika does not name its supplier either, despite having the highest trust score in the category.

Naming the supplier does not guarantee the finished product matches the raw material specification. That is what batch-level COA testing confirms. PartiQlar provides both: named supplier + batch COA. This combination is the highest level of supply chain transparency available in consumer NMN supplements.

The Enteric Coating Detail

One feature of PartiQlar's capsules that receives limited attention in most reviews is the enteric coating. Standard vegetable cellulose capsules dissolve in the stomach, exposing their contents to gastric acid (pH 1.5-3.5) and digestive enzymes. Enteric-coated capsules are designed to resist stomach acid and dissolve only in the small intestine (pH 6.0-7.4), where absorption conditions are more favorable for certain compounds.

For NMN specifically, the relevance of enteric coating is debated. NMN is water-soluble and relatively stable in acidic conditions. The Fukamizu safety trial and the Yi dose-ranging trial both used standard capsules (not enteric-coated), and both demonstrated reliable NAD+ elevation (Fukamizu et al., 2022, PMID: 36002548; Yi et al., 2023, PMID: 36482258). This means standard capsules clearly work for NMN delivery.

The enteric coating argument becomes more interesting in light of the Christen 2026 Nature Metabolism finding. If oral NMN is largely converted to nicotinic acid by gut bacteria in the small intestine before it raises systemic NAD+ (Christen et al., 2026, PMID: 41540253), then delivering NMN directly to the small intestine (bypassing the stomach) could potentially expose more intact NMN to the gut bacteria that perform this conversion. Whether this translates to higher NAD+ elevation compared to standard capsules is unknown, as no study has compared enteric-coated NMN to standard NMN in a head-to-head trial.

PartiQlar does not heavily market the enteric coating, which is either restraint or an indication that the brand recognizes the evidence is insufficient to make strong bioavailability claims. Either way, the enteric coating adds manufacturing cost (reflected in the price premium over budget brands) without proven clinical benefit over standard delivery. It is a "probably doesn't hurt, might help" feature rather than a validated advantage.

Tracing the NMN: From EffePharm Lab to PartiQlar Capsule

The NMN supply chain is one of the least discussed but most important aspects of supplement quality. Here is what the PartiQlar supply chain looks like, based on publicly available information.

Step 1: Raw material synthesis. EffePharm (Nanjing, China) produces Uthever NMN through enzymatic synthesis under ISO 9001 quality management. The company provides a raw material COA with each batch, typically including HPLC purity analysis (confirming >99% β-NMN), heavy metals screening, microbial testing, and identity confirmation. EffePharm also holds a US patent on its enzymatic NMN synthesis process.

Step 2: Raw material testing. The Uthever NMN raw material arrives at PartiQlar's US manufacturing partner with EffePharm's COA. The manufacturer independently tests the incoming raw material against the supplier's specifications before accepting it for production.

Step 3: Formulation and encapsulation. The NMN is filled into vegetable cellulose capsules with enteric coating in an NSF-certified, cGMP-compliant facility in the United States. No excipients, fillers, or flow agents are added.

Step 4: Finished product testing. The completed capsules undergo third-party batch testing at an ISO 17025-accredited laboratory. This testing verifies that the finished product matches the label claims for NMN content, purity, and safety parameters. The resulting batch COA is published on PartiQlar's website.

This four-step verification chain (supplier COA, incoming raw material test, cGMP manufacturing, finished product COA) is the gold standard in supplement quality assurance. Among the NMN brands we have reviewed, only ProHealth provides a comparable level of supply chain transparency. Most brands skip steps 1 and 2 (they do not name their NMN supplier or share the raw material COA), making it impossible for consumers to trace the molecule from source to capsule.

For a broader discussion of NMN quality verification, see our Best NMN Supplements (2026) ranking, where supply chain transparency is one of the evaluation criteria.

The Direct-to-Consumer Model: Benefits and Limitations

PartiQlar sells exclusively through partiqlar.com. This is a deliberate business decision, not a distribution limitation. The direct-to-consumer (DTC) model offers several advantages for a supplement brand, along with some tradeoffs consumers should understand.

Advantages: The brand controls the entire purchase experience, from product storage conditions (temperature-controlled warehousing) to shipping speed to customer communication. There is no risk of counterfeit products being sold under the brand's name by unauthorized third-party sellers on Amazon, a documented problem for popular NMN brands. The brand also avoids Amazon's ~15% referral fee, which allows either lower consumer pricing or higher margins reinvested into testing and quality assurance.

Limitations: Consumers cannot compare prices across retailers. There is no external marketplace review system (Amazon reviews, while imperfect, provide a large sample of consumer feedback from verified purchasers). Returns and customer service are handled exclusively by the brand, with no marketplace guarantee as a fallback. And for consumers who consolidate purchases through Amazon or other retailers for convenience, adding a separate subscription from PartiQlar's website introduces friction.

The DTC model aligns with PartiQlar's positioning as a trust-focused brand. It is a reasonable approach for a product where counterfeiting risk is real and quality perception matters. It is a less convenient approach for consumers who prefer one-click purchasing through established retail channels.

What Consumer Reviews Indicate

Because PartiQlar sells only through its own website, consumer reviews are limited to the brand's on-site system and occasional mentions on longevity forums and Reddit. This creates a smaller but potentially less manipulated review pool compared to Amazon, where both fake positive and fake negative reviews are widespread in the NMN category.

Common themes in PartiQlar reviews include perceived energy improvements within 2-4 weeks (consistent with the timeline for NAD+ elevation seen in clinical trials), appreciation for the single-ingredient simplicity, and mixed feelings about the price relative to Amazon alternatives. Some reviewers specifically cite the EffePharm/Uthever sourcing and published COAs as the reason they chose PartiQlar over cheaper options.

Negative feedback is primarily price-related. Some reviewers note that at $1.08/day, PartiQlar costs 20-30% more than comparable 500 mg NMN products from brands like Nutricost, and question whether the supply chain transparency justifies the premium. A smaller number of reviewers report no noticeable effects, which is consistent with the clinical trial data showing that NMN reliably raises NAD+ but inconsistently produces subjective improvements across all users (Zhang et al., 2025, PMID: 39116016).

One review pattern worth noting: several consumers mention switching from Amazon NMN products to PartiQlar after reading about counterfeiting concerns in the NMN market. This suggests that supply chain anxiety is a real purchase driver in this category, and that PartiQlar's transparency strategy is resonating with a specific consumer segment willing to pay a premium for traceability.

Pricing: Premium but Not Luxury

PartiQlar's pricing has shifted over time. As of late 2026, the product is available at $64.99 for 60 capsules (a 2-month supply at 1 capsule/day), which works out to approximately $1.08/day. Some sources cite $79.99 or $85.99, likely reflecting older pricing or bundle options. At $1.08/day, PartiQlar is cheaper than Cymbiotika ($2.57/day) and Wonderfeel (~$2.93/day) but more expensive than Nutricost (~$0.90/day) and Force Factor ($0.83/day).

The premium over budget brands is approximately $0.18-$0.25/day, or $5.40-$7.50/month. For that premium, you get a named raw material source (EffePharm/Uthever), published batch COAs, and a higher SuppCo trust score. Whether that premium is worth paying depends on how much you value supply chain traceability versus the lowest possible price for the same molecule at the same dose.

What the Clinical Evidence Supports at This Dose

PartiQlar's 500 mg dose is supported by the broadest evidence base in NMN supplementation. A 2025 meta-analysis pooling 12 RCTs with 513 participants confirmed that NMN at this dose range reliably elevates blood NAD+ levels (Zhang et al., 2025, PMID: 39116016). A 2023 safety review found consistent tolerability across all tested doses (Song et al., 2023, PMID: 37619764), and the Fukamizu trial confirmed safety at doses up to 1,250 mg daily (Fukamizu et al., 2022, PMID: 36002548).

The 2026 Nature Metabolism study added mechanistic depth: in 65 healthy participants, NMN supplementation doubled circulating NAD+ after 14 days, with the effect mediated partly through gut microbial conversion to nicotinic acid (Christen et al., 2026, PMID: 41540253). This finding applies equally to all oral NMN supplements at this dose, including PartiQlar. For a complete dose breakdown, see our NMN dosage guide.

Safety at 500 mg Daily: What the Trial Data Shows

PartiQlar's 500 mg dose sits well within the safety-tested range for NMN in humans. The most directly relevant safety evidence comes from three sources.

The Fukamizu trial evaluated NMN at up to 1,250 mg daily (2.5x PartiQlar's dose) for four weeks in healthy adults. No serious adverse events, no clinically meaningful changes in vital signs, and no concerning laboratory findings were observed (Fukamizu et al., 2022, PMID: 36002548). The Yi multicenter trial tested 300, 600, and 900 mg daily for 60 days, again with no serious adverse events (Yi et al., 2023, PMID: 36482258). The Song review aggregated safety data across all completed human NMN trials and found a consistently favorable safety profile (Song et al., 2023, PMID: 37619764).

The main limitation of the existing safety data is duration. Most trials ran 4-12 weeks. NMN supplements are typically used for months or years. Long-term safety data beyond 12 weeks in humans is limited, though no mechanism-based safety concern has been identified, and the NAD+ pathway that NMN feeds into is a normal part of human biochemistry. A 2022 review noted that while NMN shows an excellent short-term safety profile, long-duration monitoring data is still needed before definitive conclusions about multi-year supplementation can be drawn (Nadeeshani et al., 2022, PMID: 35499054).

For a complete discussion of reported side effects across all NMN trials, see our NMN side effects guide.

Storage and Stability Considerations

NMN is sensitive to heat, moisture, and light. A 2023 analysis of NMN degradation kinetics found that NMN in aqueous solution degrades with temperature-dependent kinetics, producing nicotinamide and ribose-5-phosphate as breakdown products (Xiang et al., 2023, PMID: 38212023). In dry capsule form with proper packaging, NMN stability is substantially better than in solution, but storage conditions still matter.

PartiQlar's 60-capsule bottle (2-month supply) means each bottle is opened and stored at room temperature for up to 60 days. For consumers in warm, humid climates, this is worth considering. The general best practice for NMN supplements is storage in a cool, dry place away from direct sunlight. Refrigeration is not typically required for sealed capsules but can extend potency in warm environments. The enteric coating on PartiQlar's capsules provides an additional moisture barrier compared to standard vegetable cellulose, which may offer a minor stability advantage during the use period.

PartiQlar's use of a 60-capsule bottle (versus the 30-capsule bottles common among competitors) means fewer reorders and fewer shipping exposures, but a longer period during which the opened bottle sits at ambient temperature. Whether this affects potency over 60 days depends on your storage conditions. If you live in a consistently temperature-controlled environment, this is unlikely to matter. If your supplement storage is subject to heat or humidity fluctuations, a 30-day supply may offer a minor freshness advantage.

Who Should Consider PartiQlar

PartiQlar makes the most sense for consumers in three specific situations.

Supply chain traceability is your top priority. Named raw material source (EffePharm/Uthever), two-layer COA verification (raw material + finished product), NSF-certified manufacturing, and direct-to-consumer distribution that eliminates counterfeiting risk. This is the full traceability package. You can trace the molecule from published clinical trial data (Uthever was used in multiple human RCTs) through the raw material manufacturer to the finished capsule on your shelf. No other consumer NMN brand at this price point provides the same depth of supply chain documentation.

You want a single-ingredient NMN to use as a stack foundation. If you already take standalone TMG, resveratrol, or quercetin at doses you have chosen based on your own research, you do not need those ingredients bundled into your NMN at sub-clinical doses. PartiQlar gives you clean NMN at a verified dose, and you control the rest of your stack independently. This is the approach that most longevity researchers and biohackers take: buy each ingredient separately at its optimal dose rather than accepting the dose compromises inherent in multi-ingredient formulas.

You have switched from Amazon NMN and want verified quality without paying luxury prices. The $1.08/day price sits between the $0.83-$0.90 budget tier (where NMN sources are undisclosed) and the $2.50+ premium tier (where you pay for brand marketing and companion ingredients). For consumers who were previously buying generic NMN Beta products on Amazon and became concerned about quality verification, PartiQlar is a logical next step that does not require a 3x price increase.

Where PartiQlar Fits in the NMN Market

By mid-2026, the NMN supplement market has stratified into distinct tiers. Understanding where PartiQlar sits helps frame whether it is the right product for your priorities.

Budget tier ($0.80-$1.00/day): Force Factor ($0.83), Nutricost ($0.90), and generic Amazon NMN Beta sellers offer 500 mg NMN at the lowest prices. Verification ranges from ISO-claimed (Nutricost) to none (most Amazon generics). NMN source is undisclosed.

Verified mid-tier ($1.00-$1.50/day): This is where PartiQlar sits, alongside YourHealthier NMN ($1.00) and ProHealth NMN Pro ($1.50). Products in this tier offer named NMN sources, published COAs, and cGMP/NSF manufacturing. The premium over budget brands ($5-15/month) buys supply chain traceability and batch-level verification.

Premium multi-ingredient ($2.50-$3.00/day): Cymbiotika ($2.57) and Wonderfeel (~$2.93) bundle NMN with companion ingredients and invest in brand positioning. The premium pays for formula complexity and, in Cymbiotika's case, the highest trust verification score in the category.

PartiQlar occupies the exact center of the verified mid-tier: more expensive than budget brands (by ~$0.18-$0.25/day), cheaper than premium multi-ingredient brands (by ~$1.50-$1.85/day), and competitive with other verified single-ingredient NMN products. For consumers who want verified NMN without paying for companion ingredients they may not need, this tier represents the best evidence-to-cost ratio in the market.

12-Month Cost Comparison

NMN supplementation is a long-term commitment. Here is what the annual numbers look like for 500 mg daily from various sources:

Product	Monthly	Annual	COA Published
Force Factor	$24.97	$300	No
Nutricost	~$27	$324	On request
YourHealthier	$29.99	$360	Yes
PartiQlar	~$32.50	$390	Yes
ProHealth	~$44.95	$539	Yes

The annual cost difference between PartiQlar and the cheapest verified NMN (YourHealthier) is $30. Between PartiQlar and the cheapest unverified NMN (Force Factor), it is $90. Whether supply chain traceability to EffePharm/Uthever is worth an extra $30-$90/year over alternatives is a question of how much uncertainty you are willing to accept about what is in your daily capsule. For some consumers, $30/year for full traceability is an easy decision. For others, the clinical trial data showing that NMN works across brands and doses makes the source less relevant than the dose and the price.

Who Should Look Elsewhere

If price is the priority, budget brands like Force Factor and Nutricost deliver the same 500 mg at 20-25% less per day. If you want companion ingredients bundled in (resveratrol, TMG, apigenin), Cymbiotika, Dr. Love, or Codeage offer multi-ingredient formulas. If you want the absolute highest trust verification score, Cymbiotika (SuppCo 9.63) outranks PartiQlar (8.2) on that single metric. For a ranked comparison of all reviewed NMN products, see our Best NMN Supplements (2026) guide.

Frequently Asked Questions

Is PartiQlar NMN third-party tested?

Yes. PartiQlar publishes batch-specific Certificates of Analysis on its website. The brand also manufactures in NSF-certified, cGMP-compliant facilities and sources its NMN from EffePharm (Uthever), which provides its own raw material COA. This two-layer testing is among the most transparent in the NMN category.

Why is PartiQlar not sold on Amazon?

The brand states this is to prevent counterfeiting and maintain product integrity. Amazon's marketplace model makes it difficult to prevent unauthorized sellers from listing relabeled or expired products under a brand's name. Several NMN brands have faced counterfeiting issues on Amazon. The tradeoff is convenience: you can only buy from partiqlar.com directly.

What is Uthever NMN?

Uthever is a branded NMN raw material manufactured by EffePharm, a Chinese pharmaceutical company. It is produced under ISO 9001 quality management and has been used in several published human clinical trials. Brands that use and disclose Uthever (including PartiQlar and ProHealth) allow consumers to trace the raw material to published research. Brands that do not name their NMN source do not provide this traceability.

Is PartiQlar NMN worth the premium over Nutricost?

The cost difference is approximately $5-7/month for comparable dosing. For that premium, you get a named raw material source, published batch COAs, and direct-to-consumer sales (reducing counterfeiting risk). Nutricost claims ISO 17025-accredited testing but does not proactively publish batch-level COAs. Whether supply chain traceability is worth $5-7/month is a personal value judgment.

How does PartiQlar compare to ProHealth NMN?

Both brands use EffePharm Uthever NMN, publish batch COAs, and offer single-ingredient formulas. ProHealth has a broader NMN product range (capsules, powder, sustained-release, liposomal) and a longer track record in the market. PartiQlar offers a more focused product line at a lower price point ($1.08/day vs $1.50/day for comparable capsules). Both are strong choices in the verified mid-tier; the decision often comes down to product format preference and pricing.

Is PartiQlar NMN the same as Uthever NMN?

PartiQlar uses Uthever NMN as its raw material, but the finished product is not identical to buying Uthever directly. PartiQlar adds enteric coating to the capsule, conducts finished-product batch testing (separate from EffePharm's raw material testing), and packages/distributes the product under its own quality control. Uthever is the ingredient; PartiQlar is the finished supplement with its own manufacturing and testing layer on top.

Can I buy PartiQlar on Amazon?

No. PartiQlar is available only through partiqlar.com. The brand does not sell on Amazon, Walmart, or other third-party retailers. Any listing claiming to sell PartiQlar on these platforms is unauthorized and may be counterfeit. This direct-to-consumer approach reduces counterfeiting risk but limits purchase convenience.

Should I take PartiQlar NMN with TMG?

PartiQlar does not include TMG (trimethylglycine) in its formula. Some longevity researchers suggest TMG may support methylation during NAD+ synthesis, though no clinical trial has tested NMN+TMG versus NMN alone. If methylation support matters to you, adding standalone TMG at 500-3,000 mg daily is an option. See our NMN guide for a discussion of the methylation question.

References

1. Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229. PMID: 33888596
2. Yi L, Maier AB, Tao R, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults. Geroscience. 2023;45(1):29-43. PMID: 36482258
3. Igarashi M, Nakagawa-Nagahama Y, Miura M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. NPJ Aging. 2022;8(1):5. PMID: 35927255
4. Fukamizu Y, Uchida Y, Shigekawa A, et al. Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women. Sci Rep. 2022;12(1):14442. PMID: 36002548
5. Song Q, Zhou X, Xu K, et al. The safety and antiaging effects of nicotinamide mononucleotide in human clinical trials: an update. Adv Nutr. 2023;14(6):1416-1435. PMID: 37619764
6. Zhang J, Poon ETC, Wong SHS, et al. Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism: a systematic review with meta-analysis. Crit Rev Food Sci Nutr. 2025. PMID: 39116016
7. Christen S, Cuenoud B, et al. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nat Metab. 2026. PMID: 41540253
8. Nadeeshani H, Li J, Ying T, et al. Nicotinamide mononucleotide (NMN) as an anti-aging health product: promises and safety concerns. J Adv Res. 2022;37:267-275. PMID: 35499054
9. Xiang DH, et al. Degradation kinetics of β-nicotinamide mononucleotide in aqueous solution. Zhongguo Zhong Yao Za Zhi. 2023. PMID: 38212023

Disclaimer: This article is for informational purposes only and does not constitute medical advice. NMN supplements are not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before beginning any supplement regimen.